title: Reply to the "Comments on the article 'Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations'", by Avogaro (Journal of Diabetes and Its Complications 25 [2011] 352-353).
authors.forename: Raffaele
authors.initials: R
authors.lastname: Marfella
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Paolisso
mesh_terms: D000218:Adamantane / Q000031:analogs & derivatives*; D001786:Blood Glucose / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009570:Nitriles / Q000008:administration & dosage*; D011719:Pyrazines / Q000008:administration & dosage*; D011759:Pyrrolidines / Q000008:administration & dosage*; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D001786:Blood Glucose; D054873:Dipeptidyl-Peptidase IV Inhibitors; D009570:Nitriles; D011719:Pyrazines; D011759:Pyrrolidines; D014230:Triazoles; D000218:Adamantane